Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s669. https://doi.org/10.25251/2vrcdb23